Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP460859.RA29182C_YCqP9dzPGgdITlJb9sjF_5HTpZaswzq1xSBk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP460859.RA29182C_YCqP9dzPGgdITlJb9sjF_5HTpZaswzq1xSBk130_assertion type Assertion NP460859.RA29182C_YCqP9dzPGgdITlJb9sjF_5HTpZaswzq1xSBk130_head.
- NP460859.RA29182C_YCqP9dzPGgdITlJb9sjF_5HTpZaswzq1xSBk130_assertion description "[Thus, TNFalpha antagonists and especially 5LOX inhibitors might offer new opportunities for treatment of ALS.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP460859.RA29182C_YCqP9dzPGgdITlJb9sjF_5HTpZaswzq1xSBk130_provenance.
- NP460859.RA29182C_YCqP9dzPGgdITlJb9sjF_5HTpZaswzq1xSBk130_assertion evidence source_evidence_literature NP460859.RA29182C_YCqP9dzPGgdITlJb9sjF_5HTpZaswzq1xSBk130_provenance.
- NP460859.RA29182C_YCqP9dzPGgdITlJb9sjF_5HTpZaswzq1xSBk130_assertion SIO_000772 15379894 NP460859.RA29182C_YCqP9dzPGgdITlJb9sjF_5HTpZaswzq1xSBk130_provenance.
- NP460859.RA29182C_YCqP9dzPGgdITlJb9sjF_5HTpZaswzq1xSBk130_assertion wasDerivedFrom befree-2016 NP460859.RA29182C_YCqP9dzPGgdITlJb9sjF_5HTpZaswzq1xSBk130_provenance.
- NP460859.RA29182C_YCqP9dzPGgdITlJb9sjF_5HTpZaswzq1xSBk130_assertion wasGeneratedBy ECO_0000203 NP460859.RA29182C_YCqP9dzPGgdITlJb9sjF_5HTpZaswzq1xSBk130_provenance.